In vitro generation of mature human osteoclasts

Calcified Tissue International

Volumn 89, Issue 5, 2011, Pages 389-395

  Hemingway, F ^a   Cheng, X ^a   Knowles, H J ^a   Estrada, F Martinez ^b   Gordon, S ^b   Athanasou, N A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bisphosphonate; Osteoclast; RANKL

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN; CATHEPSIN K; CD14 ANTIGEN; COLONY STIMULATING FACTOR 1; F ACTIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; VITRONECTIN RECEPTOR; ZOLEDRONIC ACID;

ARTICLE; CELL ISOLATION; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; CULTURE TECHNIQUE; HUMAN; HUMAN CELL; IN VITRO STUDY; LACUNAR RESORPTION; MONOCYTE; MULTINUCLEAR CELL; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD14; BONE RESORPTION; CALCITONIN; DIPHOSPHONATES; HUMANS; IMIDAZOLES; MICROSCOPY, PHASE-CONTRAST; MONOCYTES; OSTEOCLASTS; OSTEOPROTEGERIN;

EID: 82755182583     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-011-9530-0     Document Type: Article

References (31)

1. Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA (1996) The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137:4058-4060 (Pubitemid 26284685)
2. Quinn JM, Sabokbar A, Athanasou NA (1996) Cells of the mononuclear phagocyte series differentiate into osteoclastic lacunar bone resorbing cells. J Pathol 179:106-111 (Pubitemid 26180087)
3. Roodman GD (1996) Paget's disease and osteoclast biology. Bone 19:209-212 (Pubitemid 26302603)
4. Quinn JM, Elliott J, Gillespie MT, Martin TJ (1998) A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139:4424-4427 (Pubitemid 28513734)
5. Chambers TJ, Fuller K, McSheehy PM, Pringle JA (1985) The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells. J Pathol 145:297-305
6. Lau YS, Sabokbar A, Gibbons CL, Giele H, Athanasou N (2005) Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Hum Pathol 36:945-954 (Pubitemid 41253379)
7. Chambers TJ, Revell PA, Fuller K, Athanasou NA (1984) Resorption of bone by isolated rabbit osteoclasts. J Cell Sci 66: 383-399 (Pubitemid 14051778)
8. Oursler MJ, Collin-Osdoby P, Anderson F, Li L, Webber D, Osdoby P (1991) Isolation of avian osteoclasts: improved techniques to preferentially purify viable cells. J Bone Miner Res 6: 375-385
9. Osdoby P, Kruhowshi M, Collin-Osdoby P (1992) Experimental systems for studying osteoclast biology. In: Rifkin B, Gay C (eds) Biology and physiology of the osteoclast. CRC Press, New York, pp 1-32
10. Murrills RJ, Shane E, Lindsay R, Dempster DW (1989) Bone resorption by isolated human osteoclasts in vitro: effects of calcitonin. J Bone Miner Res 4:259-268 (Pubitemid 19121802)
11. Chambers TJ, Dunn CJ (1983) Pharmacological control of osteoclastic motility. Calcif Tissue Int 35:566-570 (Pubitemid 13028631)
12. McSheehy PM, Chambers TJ (1986) Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 118:824-828 (Pubitemid 16162808)
13. McSheehy PM, Chambers TJ (1987) 1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. J Clin Invest 80:425-429
14. Minkin C (1982) Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34:285-290 (Pubitemid 12060442)
15. Littlewood-Evans A, Kokubo T, Ishibashi O, Inaoka T, Wlodarski B, Gallagher JA, Bilbe G (1997) Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone 20:81-86 (Pubitemid 27086994)
16. Horton MA, Lewis D, McNulty K, Pringle JA, Chambers TJ (1985) Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. Cancer Res 45:5663-5669 (Pubitemid 16218570)
17. Yoshida S, Domon T, Wakita M (1989) Studies of the clear zone of osteoclasts: immunohistological aspects of its form and distribution. Arch Histol Cytol 52:513-520 (Pubitemid 20125665)
18. Chambers TJ (1979) Phagocytosis and trypsin-resistant glass adhesion by osteoclasts in culture. J Pathol 127:55-60
19. Chambers TJ, Magnus CJ (1982) Calcitonin alters behaviour of isolated osteoclasts. J Pathol 136:27-39 (Pubitemid 12213616)
20. Takahashi S, Goldring S, Katz M, Hilsenbeck S, Williams R, Roodman GD (1995) Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Invest 95:167-171
21. Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, Shinki T, Gillespie MT, Martin TJ, Higashio K, Suda T (2000) Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141: 3478-3484 (Pubitemid 32269038)
22. Capparelli C, Morony S, Warmington K, Adamu S, Lacey D, Dunstan CR, Stouch B, Martin S, Kostenuik PJ (2003) Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmacokinetic analysis in rats. J Bone Miner Res 18:852-858 (Pubitemid 37294968)
23. Romas E, Sims NA, Hards DK, Lindsay M, Quinn JW, Ryan PF, Dunstan CR, Martin TJ, Gillespie MT (2002) Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen- induced arthritis. Am J Pathol 161:1419-1427
24. Hakeda Y, Kobayashi Y, Yamaguchi K, Yasuda H, Tsuda E, Higashio K, Miyata T, Kumegawa M (1998) Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. Biochem Biophys Res Commun 251:796-801 (Pubitemid 28512790)
25. Atkins GJ, Bouralexis S, Haynes DR, Graves SE, Geary SM, Evdokiou A, Zannettino AC, Hay S, Findlay DM (2001) Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone. Bone 28:370-377 (Pubitemid 32385408)
26. Burgess TL, Qian Y, Kaufman S, Ring BD, Van G, Capparelli C, Kelley M, Hsu H, Boyle WJ, Dunstan CR, Hu S, Lacey DL (1999) The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol 145:527-538 (Pubitemid 29215717)
27. Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC (2000) Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88:2961-2978 (Pubitemid 30413179)
28. Kimmel DB (2007) Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogencontaining bisphosphonates. J Dent Res 86:1022-1033
29. Kirstein B, Grabowska U, Samuelsson B, Shiroo M, Chambers TJ, Fuller K (2006) A novel assay for analysis of the regulation of the function of human osteoclasts. J Transl Med 4:45
30. Susa M, Luong-Nguyen NH, Cappellen D, Zamurovic N, Gamse R (2004) Human primary osteoclasts: in vitro generation and applications as pharmacological and clinical assay. J Transl Med 2:6
31. Fuller K, Ross JL, Szewczyk KA, Moss R, Chambers TJ (2010) Bone is not essential for osteoclast activation. PLoS One 5(9)